Showing results (491-500 of 779) with videos related to

Sort By:
Pageof 78
The American Journal of Cardiology|May 31, 2026
Flow Normalization and Left Ventricular Ejection Fraction Improvement After Transcatheter Aortic Valve Replacement Across Low-Flow Aortic Stenosis PhenotypesChisom Enwere, Roya Anahita Mousavi, Pragati Basera, et al.
European Heart Journal|June 1, 2026
Standard modifiable risk factors among patients undergoing percutaneous coronary intervention: prevalence and impactJohny Nicolas, Angelo Oliva, Rebecca Cohen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 26, 2019
Influence of final kissing balloon inflation on long-term outcomes after PCI of distal left main bifurcation lesions in the EXCEL trialAnnapoorna S Kini, George D Dangas, Usman Baber, et al.
European Heart Journal|July 5, 2019
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trialsPaul Guedeney, Gennaro Giustino, Sabato Sorrentino, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 6, 2004
Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis modelNicholas N Kipshidze, Patrick Iversen, Han-Soo Kim, et al.
Cardiovascular Radiation Medicine|February 27, 2004
Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis modelNicholas N Kipshidze, Thomas R Porter, George Dangas, et al.
The American Journal of Cardiology|April 26, 2006
A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique"Issam Moussa, Ricardo A Costa, Martin B Leon, et al.
The Canadian Journal of Cardiology|March 9, 2025
Potent P2Y12 Inhibitors vs Clopidogrel in Cancer Patients Undergoing Percutaneous Coronary InterventionMauro Gitto, Samantha Sartori, Birgit Vogel, et al.
Pageof 78